Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.

Journal of geriatric psychiatry and neurology - 1 May 2022

Alber Jessica, Popescu Dominique, Thompson Louisa I, Tonini Gina-Marie, Arthur Edmund, Oh Hwamee, Correia Stephen, Salloway Stephen P, Lee Athene K

Abstract excerpt

AIMS: Alzheimer's disease (AD) is a gradually progressive neurodegenerative disease that ultimately results in total loss of cognitive and functional independence in older adults. This study aimed to examine the safety and tolerability of APOE disclosure in community-dwelling, cognitively normal (CN) older adults from the Butler Alzheimer's Prevention Registry (BAPR), and to determine whether APOE disclosure...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Apolipoproteins E

Share to Disclosure

Share to Healthy Volunteers

Share to Neurodegenerative Diseases

Share to Registries

Source

Identifiers

PMID: 33550928
DOI: 10.1177/0891988721993575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.PMID 33550928Read ↗

The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer's Prevention Registry.Semantic proximity Read ↗

Disclosure of APOE genotype for risk of Alzheimer's disease.Semantic proximity Read ↗

APOE Genotype Disclosure Influences Decisions About Future Planning but not Adoption of Healthy Lifestyle Changes in Cognitively Unimpaired Individuals.Semantic proximity Read ↗

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.Semantic proximity Read ↗

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.Semantic proximity Read ↗

Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1.Semantic proximity Read ↗

Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies (WeSHARE)Semantic proximity Read ↗

Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention.Semantic proximity Read ↗

Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.Semantic proximity Read ↗

Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress.Semantic proximity Read ↗

Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).Semantic proximity Read ↗

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: A survey studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.